Non-invasive diagnosis and assessment of patients with chronic hepatitis C (CHC): The importance of serum proteome profiling with SELDI-TOF-MS – preliminary results — Erbil Yağmur (2006) | RDL Network
Non-invasive diagnosis and assessment of patients with chronic hepatitis C (CHC): The importance of serum proteome profiling with SELDI-TOF-MS – preliminary results
Article 2006 en
Authors
EY
Erbil Yağmur
RK
RC Krieg
HW
HE Wasmuth
Abstract
1 min read
Aims: Liver biopsy is the gold standard to assess whether or not fibrosis in CHC is advancing, stable or regressing and to provide prognostic and therapeutic information. A promising approach to non-invasive biomarker discovery referring to diagnose CHC and differentiating mild from moderate/advanced stage of liver disease is protein profiling using surface enhanced laser desorption/ionisation (SELDI)-based ProteinChip® technology.
Arndt Vogel, Andrés Cervantes, Ian Chau, Bruno Daniele, Josep M. Llovet, Tim Meyer, Jean‐Charles Nault, Ulf P. Neumann, Jens Ricke, Bruno Sangro, Peter Schirmacher, Chris Verslype, Francis Zech, Dirk Arnold, Erika Martinelli
Discussion(0)
No comments yet. Be the first to comment.